Releases by Year
For viewer convenience, this page lists both news releases and press releases for year 2015
News Releases and Press Releases for 2016
August 29,2016 NR:
FDA Grants Orphan-Drug Designation for Regenicin's NovaDerm® Cultured Skin Substitute
click to read artictle. This takes you to the article on the PR Newswire website. Click the News Releases button on the top (blue) menu to return.
February 9, 2016:
Regenicin Reports 2015 Operating Results, Outlines Milestones for Q1 2016
click to read artictle This takes you to the article on the PR Newswire website. Click the News Releases button on the top menu (blue) to return.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SOURCE: Regenicin, Inc.